Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, TRI

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference



LUND, Sweden, Jan. 4, 2018 /PRNewswire/ --

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing tumor-directed immunotherapies, today announced that the company is scheduled to present at the 10th Annual Biotech Showcase conference held 8-10 January, 2018 in San Francisco, US.

Chief Executive Officer Per Norlén will give an update on the company's clinical stage project ADC-1013, out-licensed to Janssen Biotech Inc., as well as the near-clinical bispecific antibody ATOR-1015 and the preclinical projects ALG.APV-527 and ATOR-1017.

The presentation will take place on 8 January, at 10:30 a.m. PST /8 Jan 7:30 p.m. CET. The audio and slide presentation will be webcasted live and can be accessed via the Alligator web site. To access the presentation, live and replay, please go to https://event.webcasts.com/starthere.jsp?ei=1175723&tp_key=101995f0f8.

The information was submitted for publication, through the agency of the contact person set out above, at 11:00 a.m. CET on 4 January 2018.

About Alligator Bioscience
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immunotherapies. Alligator's growing pipeline includes four lead clinical and pre-clinical therapeutic antibodies (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

For further information, please contact:
Cecilia Hofvander,
Director Investor Relations & Communications
Phone +46-46-286-44-95
E-mail: cecilia.hofvander@alligatorbioscience.com

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/alligator-bioscience/r/alligator-bioscience-to-present-at-the-10th-annual-biotech-showcase-conference,c2425257

The following files are available for download:

http://mb.cision.com/Main/12681/2425257/773833.pdf

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference

 


These press releases may also interest you

at 06:00
Transparency Market Research (TMR) has published a new report titled, "Plasma Fractionation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026". According to the report, the global plasma fractionation market was...

at 06:00
Marken announced today that Brazil's ANVISA has approved shipments of biological samples from Sao Paulo's Viracopos airport to the United States using the UPS airline. The pilot program approved by the Brazilian authorities will allow biologic...

at 06:00
DENVER, Aug. 21, 2018 /PRNewswire-PRWeb/ -- Enquire, a leading provider of cloud CRM and sales contact center solutions for senior living and post-acute communities, is proud to announce Linkmedia 360 as the Diamond Sponsor of Enquire Summit,...

at 06:00
BEVERLY HILLS, Calif., Aug. 21, 2018 /PRNewswire-PRWeb/ -- The Centers for Disease Control and Prevention (CDC) just released provisional data showing 70,689 drug overdose deaths in 2017. This is the highest overdose death rate on record and reflects...

at 06:00
The "Surgical Suture Market to 2025 - Global Analysis and Forecasts By Product, Application and Geography" report has been added to ResearchAndMarkets.com's offering. While conducting the study for surgical sutures, we have segmented the surgical...

at 06:00
Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced receipt of a $3 million Small Business Innovation Research (SBIR) grant from the National Institutes of...




News published on 4 january 2018 at 05:25 and distributed by: